Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
J Card Surg. 2022 Oct;37(10):3313-3321. doi: 10.1111/jocs.16853. Epub 2022 Aug 18.
Connective tissue disorders predispose patients to earlier aortic dissections and aneurysms. However, there is limited large cohort data given its low incidence.
The National Inpatient Sample was searched for all adults with Marfans (MFS) and Ehlers Danlos (EDS) disease between 2010 and 2017. ICD codes were used to select those with a type A aortic dissection or aneurysm.
There was a total of 19,567 cases, giving the estimated incidence of MFS and EDS of 18 and 22.4 per 100k people, respectively. After inclusion criteria, there were 2553 MF and 180 EDS patients. There was no statistical difference in mortality between the MFS and EDS cohorts (4.6% vs. 2.8%, p = .26). EDS patients were more likely to undergo a TEVAR procedure (2.8% vs. 1.0%, p = .03). MF patients were more likely to have a complication of acute kidney injury (p = .02). EDS patients were more likely older (50 vs. 42, p < .001) and female (47% vs. 33%, p < .001). MFS patients were more likely to have a type A aortic dissection (44% vs. 31%, p < .001). The majority (89%) of patients were treated at urban teaching hospitals. On univariable logistic regression, aortic dissection was a predictor for mortality (odds ratio 7.31, p < .001). The type of connective tissue disease was not a significant predictor.
National level estimates show low mortality for patients with MF or ED presenting to the hospital with aortic dissection or aneurysm. The differences in age and gender can guide surveillance for these patient populations, leading to more elective admissions and reduced hospital mortality.
结缔组织疾病使患者更容易发生主动脉夹层和动脉瘤。然而,由于其发病率较低,因此只有有限的大型队列数据。
在 2010 年至 2017 年期间,国家住院患者样本中搜索了所有马凡氏综合征(MFS)和埃勒斯-当洛斯综合征(EDS)成年患者。使用 ICD 编码选择患有 A 型主动脉夹层或动脉瘤的患者。
共有 19567 例患者,MFS 和 EDS 的发病率分别为每 10 万人 18 例和 22.4 例。经过纳入标准,共有 2553 例 MFS 和 180 例 EDS 患者。MFS 和 EDS 两组的死亡率无统计学差异(4.6%对 2.8%,p=0.26)。EDS 患者更有可能接受 TEVAR 手术(2.8%对 1.0%,p=0.03)。MFS 患者更有可能出现急性肾损伤并发症(p=0.02)。EDS 患者年龄更大(50 岁对 42 岁,p<0.001),女性比例更高(47%对 33%,p<0.001)。MFS 患者更有可能患有 A 型主动脉夹层(44%对 31%,p<0.001)。大多数患者(89%)在城市教学医院接受治疗。在单变量逻辑回归中,主动脉夹层是死亡的预测因素(比值比 7.31,p<0.001)。结缔组织疾病的类型不是死亡的显著预测因素。
国家层面的估计显示,患有 MFS 或 ED 的患者因主动脉夹层或动脉瘤就诊,其死亡率较低。年龄和性别差异可以指导这些患者群体的监测,从而增加选择性入院和降低医院死亡率。